Literature DB >> 19104443

Immunocytochemical detection of newly generated neurons in the perilesional area of cortical infarcts after intraventricular application of brain-derived neurotrophic factor.

Silke Keiner1, Otto W Witte, Christoph Redecker.   

Abstract

The adult brain responds to focal infarction with proliferation of glial subpopulations. In addition, cells that express the immature neuronal marker doublecortin have been found consistently in the perileisonal zone. We investigated whether application of brain-derived neurotrophic factor (BDNF) would influence this perilesional proliferative response. Photothrombotic infarcts were induced in the sensorimotor forelimb and hindlimb cortex of adult rats. Brain-derived neurotrophic factor or vehicle was continuously infused intraventricularly for 2 weeks after the infarct using osmotic minipumps. Proliferating cells were labeled by daily intraperitoneal injections of bromodeoxyuridine during the first 2 weeks and were quantified at days 14 and 42 using semiautomatic stereology. Triple immunofluorescence with antibodies against immature and mature neuronal and glial markers was used to identify the proliferating cell populations. On day 14 after intraventricular BNDF application, the numbers of doublecortin-positive cells were doubled in the perilesional zone. On day 42, BDNF-treated animals had a small number of mature neurons in these areas, whereas vehicle-treated controls did not. Behavioral analysis with a battery of sensorimotor tests revealed, however, that the alterations in the perilesional cellular response were not associated with an improved functional outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19104443     DOI: 10.1097/NEN.0b013e31819308e9

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

Review 1.  Neurogenesis following Stroke Affecting the Adult Brain.

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-11-02       Impact factor: 10.005

2.  Two distinct populations of doublecortin-positive cells in the perilesional zone of cortical infarcts.

Authors:  Albrecht Kunze; Alexandra Achilles; Silke Keiner; Otto W Witte; Christoph Redecker
Journal:  BMC Neurosci       Date:  2015-04-15       Impact factor: 3.288

3.  Mitochondrial Dysfunction in Astrocytes Impairs the Generation of Reactive Astrocytes and Enhances Neuronal Cell Death in the Cortex Upon Photothrombotic Lesion.

Authors:  Christian Fiebig; Silke Keiner; Birgit Ebert; Iris Schäffner; Ravi Jagasia; D Chichung Lie; Ruth Beckervordersandforth
Journal:  Front Mol Neurosci       Date:  2019-02-22       Impact factor: 5.639

4.  A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion.

Authors:  Yu-Chen Chen; Ning-Xin Ma; Zi-Fei Pei; Zheng Wu; Fabricio H Do-Monte; Susan Keefe; Emma Yellin; Miranda S Chen; Jiu-Chao Yin; Grace Lee; Angélica Minier-Toribio; Yi Hu; Yu-Ting Bai; Kathryn Lee; Gregory J Quirk; Gong Chen
Journal:  Mol Ther       Date:  2019-09-06       Impact factor: 11.454

5.  Brain-derived neurotrophic factor promotes vasculature-associated migration of neuronal precursors toward the ischemic striatum.

Authors:  Sofia Grade; Yuan C Weng; Marina Snapyan; Jasna Kriz; João O Malva; Armen Saghatelyan
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

Review 6.  Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases.

Authors:  Junying Cai; Fuzhou Hua; Linhui Yuan; Wei Tang; Jun Lu; Shuchun Yu; Xifeng Wang; Yanhui Hu
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

7.  Growth Hormone Promotes Motor Function after Experimental Stroke and Enhances Recovery-Promoting Mechanisms within the Peri-Infarct Area.

Authors:  Sonia Sanchez-Bezanilla; N David Åberg; Patricia Crock; Frederick R Walker; Michael Nilsson; Jörgen Isgaard; Lin Kooi Ong
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.